B3GAT1 and chronic myelogenous leukemia, BCR-ABL1 positive: CML patients in MMR and MR4.5 on TKI display a more mature, cytolytic CD57+CD62L− NK cell phenotype, consistent with restoration of NK cell activating and inhibitory receptor repertoire compared to their downregulation at diagnosis (12).